Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

University of Colorado Hospital

Study ID

Protocol Number: 18-2051

More information available at ClinicalTrials.gov: NCT03410043

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers